tirzepatide twice weekly dosing Mounjaro (tirzepatide) - Diabetes & Wieght Loss I’m currently micro-dosing Tirzepatide to

No validated human pharmacokinetics A human half-life, bioavailability, tissue distribution, metabolic pathway and exposure-response relationship have not been established through a published clinical programme

Diabetes Metab Syndr Clin Res Rev 15(4):102188 Chavda VP et al (2022) Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review

One potential mechanism is that H 2 S 2 and H 2 S 3 produced by 3MST readily react with free cysteine and GSH to produce Cys-SSH and GSSH, and react with cysteine residues of proteins to generate persulfurated proteins (Figs 2 and 8a)

This imbalance allows CD to grow in number and produce toxins

Coverage and results are not guaranteed